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After the landmark studies reporting changes in the cer-
ebral metabolic rate of glucose (CMRGlc) in excess of
those in oxygen (CMRO2) during physiological stimula-
tion, several studies have examined the fate of the
extra carbon taken up by the brain, reporting a wide
range of changes in brain lactate from 20% to 250%.
The present study reports functional magnetic reso-
nance spectroscopy measurements at 7 Tesla using the
enhanced sensitivity to study a small cohort (n 5 6).
Small increases in lactate (19% 6 4%, P < 0.05) and
glutamate (4% 6 1%, P < 0.001) were seen within the
first 2 min of activation. With the exception of glucose
(12% 6 5%, P < 0.001), no other metabolite concen-
tration changes beyond experimental error were signifi-
cantly observed. Therefore, the present study confirms
that lactate and glutamate changes during physiological
stimulation are small (i.e. below 20%) and shows that
the increased sensitivity allows reproduction of previous
results with fewer subjects. In addition, the initial rate
of glutamate and lactate concentration increases
implies an increase in CMRO2 that is slightly below
that of CMRGlc during the first 1–2 min of
activation. VC 2013 Wiley Periodicals, Inc.
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At physiological resting state, cerebral metabolic
rate of glucose (CMRGlc), cerebral blood flow (CBF),
and cerebral metabolic rate of oxygen (CMRO2) are
generally considered to be tightly coupled (Fox and
Raichle, 1986; Fox et al., 1988), with energy needs sup-
ported mainly by glucose oxidation. Nonetheless, during
visual stimulation, significant uncoupling of the changes
of CMRGlc (DCMRGlc 5 22–50%), of CBF (DCBF 5
30–65%), and of CMRO2 (DCMRO2 5 5–30%) have
been reported for the human brain (Fox and Raichle,
1986; Fox et al., 1988; Chen et al., 1993; Madsen et al.,
1995; Kim and Ugurbil, 1997; Davis et al., 1998; Liu
et al., 2004; Zhu et al., 2009; Leithner et al., 2010; Lin
et al., 2010; Wey et al., 2011). Such uncoupling during
physiological stimulation forms the basis of the blood-
oxygen-level-dependent effect (BOLD) used in func-
tional magnetic resonance imaging (fMRI; Lin et al.,
2010, and references therein). Furthermore, Fox et al.
(1988) proposed that increased neuronal activity requires
only small amounts of chemical energy produced by oxi-
dative phosphorylation. However, given the high ATP
yield of oxidative phosphorylation, glucose oxidation
may still be considered as a major source of energy dur-
ing physiological stimulation (Rothman et al., 2003).
Aerobic glycolysis (i.e., production of lactate) has thus
been suggested to explain the observed uncoupling.
Investigation of brain lactate concentration changes
during stimulation has led to variable results in the
human brain such as a major increase (Prichard et al.,
1991; Sappey-Marinier et al., 1992), a transient increase
(Frahm et al., 1996), or the absence of changes
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(Merboldt et al., 1992; Sandor et al., 2005). However, a
recent study involving 12 subjects using the high sensi-
tivity of magnetic resonance spectroscopy (MRS) at 7
Tesla (T) and optimized functional MRS (fMRS) meth-
odology reported a small but sustained increase of lactate
during visual stimulation (23% 6 5%; Mangia et al.,
2007). An optimized implementation of the MRS
sequence stimulated-echo acquisition mode (STEAM)
sequence (Tkac and Gruetter, 2005, and references
therein) that allows recording signal at short echo times
was used in that study. More recently, two studies have
also shown a lactate increase of 50% 6 5% (n 5 12 [Lin
et al., 2010] at 3T) and 10% 6 6% (n 5 8 [Lin et al.,
2012] at 7T) during visual stimulation using STEAM.
All of the aforementioned studies were performed
at B0 fields lower than 7 T, except for those of Mangia
et al. (2007) and Lin et al. (2012), which used STEAM
localization that incurs a nearly twofold lower sensitivity
than theoretically possible with a spin-echo-based
sequence (Mlynarik et al., 2006; Mekle et al., 2009). For
all studies of dynamic concentration changes using
fMRS, a reliable measurement of the time evolution is
advantageous for the characterization of the very small
transient changes (about 0.2 lmol/g) used in the subse-
quent analysis of metabolic rates. Therefore, measure-
ments with the highest possible sensitivity are desirable.
In this study, proton MR spectra were acquired with
the spin-echo full-intensity acquired localized (SPE-
CIAL) sequence, allowing for full signal acquisition at
short echo time (TE; Mlynarik et al., 2006; Mekle et al.,
2009) in combination with the use of a high magnetic
field system (7T) and the advantages that it provides
(Tkac and Gruetter, 2005).
During physiological stimulation, brain cells require
energy for neuronal firing and the replenishment of neu-
rotransmitter, of which glutamate is the most prominent
(Fonnum, 1984; Erecinska and Silver, 1990). Glucose is
the primary substrate for energy metabolism and an
increase in its metabolism during functional activity leads
to an incremental increase in energy production (ATP)
mainly via the TCA cycle.
Therefore, the aim of the present study was to use
the enhanced sensitivity of a spin-echo-based acquisition
technique to characterize metabolite changes during
functional activation in general and to confirm the
results from a previous study (Mangia et al., 2007; Lin
et al., 2012) in fewer subjects.
MATERIALS AND METHODS
MR Protocol
Ten healthy volunteers (one female, nine males, 20–28
years) participated in the study and gave informed consent
according to a procedure approved by the local ethics commit-
tee. The experiments were performed on a 7-T/68-cm (Siemens
Healthcare, Erlangen, Germany) scanner with the use of a
home-built quadrature transmit/receive surface coil (diameter 13
cm). All of the participants were subjected to the same experi-
ment and functional paradigm. Anatomical images were acquired
using a multislice gradient echo imaging sequence. A ‘‘localizer’’
fMRI experiment was then performed using a multislice EPI
sequence similar to the one described by van der Zwaag et al.
(2009). The activation paradigm consisted of a 9-Hz reversed
black–grey checkerboard, alternating with a black screen with
the following timing: 10 sec on–20 sec off (total acquisition time
[TA] 2 min 30 sec). The stimulus was presented on a screen cov-
ering the back of the magnet bore. Based on anatomical land-
marks, the MRS voxel (VOI 5 20 3 22 3 20 mm3) was placed
either inside the BOLD-activated volume (primary visual cor-
tex in both hemispheres, referred to as ‘‘activated tissue’’; n 5
6), or outside the BOLD-activated volume (above the primary
visual cortex, referred to as ‘‘nonactivated tissue’’; n 5 4). A
localized calibration of the RF transmitter voltage was then per-
formed for the selected VOI. All first- and second-order shim
terms were adjusted using FAST(EST)MAP (Gruetter, 1993;
Gruetter and Tkac, 2000) to minimize B0 homogeneities over
the volume of interest.
During the fMRS measurements, 1H spectra were
continuously acquired. A SPECIAL localization sequence
(Mlynarik et al., 2006; TR/TE 5 5,000/6 msec, BW 5
4,000 Hz, vector size 5 2,048 pts, carrier frequency of the
pulses set to 2.35 ppm off-resonance from water peak) with
two averages was used. The SPECIAL sequence was preceded
by VAPOR water suppression (WS) interleaved with blocks
of outer volume saturation (OVS) used to minimize the water
signal and lipid signals from extracerebral fat tissue (Tkac and
Gruetter, 2005). In addition to the optimization of the flip
angles of the WS pulses for each subject, the OVS bands were
carefully placed to minimize lipid contamination of the 1H
spectra. The functional paradigm employed for the fMRS
experiment consisted of the same black–grey checkerboard as
that employed for the ‘‘localizer’’ experiment, but the timing
was different: five periods of 5 min (off–on–off–on–off, TA 5
25 min) were acquired. A red cross was placed in the center
of the screen, and subjects were asked to report rotations of
the fixation cross via a button press.
Data Processing
The acquired free induction decays (FIDs) were sepa-
rately stored for each pair of scans. Spectral quality was such
that neither additional water removal nor baseline correction
was necessary or applied. After Fourier transformation, spectra
were frequency corrected to compensate for small B0 drift as
described by Tkac and Gruetter (2005). We checked rigor-
ously for lipid contamination. Specifically, the ratio of the
height of the NAA peak to the height of the sum of macro-
molecules and lipid resonances (at 0.89 ppm, 1.22 ppm, 1.41
ppm, and 1.7 ppm) was allowed to deviate by less than 20%
of the mean value. Spectra that did not satisfy this condition
were discarded. Finally, prior to quantification, spectra were
averaged into blocks of various sizes following three
approaches, as described below.
In the first approach, MR spectra were individually ana-
lyzed, with FIDs averaged into blocks of six scans each. A
mean time course was obtained by averaging the metabolite
concentrations across all six subjects for whom the MRS voxel
was placed in activated tissue. To reduce temporal fluctua-
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tions, a moving average with a kernel of four scans was
applied after quantification for the plot of individual time
courses. In addition, for each individual subject, metabolite
concentration changes between activation and rest periods
(time course analysis) were obtained by comparing the last 40
scans of the two activation blocks to the last two rest blocks,
i.e., 1H spectra acquired during the last 3.3 min of each
5-min block. The time course analysis of the metabolite
concentration changes was performed by using a two-way
ANOVA with Bonferroni posttest correction. The same aver-
aged spectra were used to obtain individual difference spectra.
In the second approach, MR spectra were combined
across subjects prior to quantification to perform a group anal-
ysis. Each time point was the average of 24 scans (4 scans/sub-
ject, n 5 6) for the activated tissue, and an average of 16 scans
was used (4 scans/subject, n 5 4) for the nonactivated tissue,
leading to 75 points in the mean time course. A moving aver-
age with four scans kernel was applied after quantification for
the plot of the mean time courses. A comparison of the time
courses from voxels placed outside (nonactivated tissue) and
inside (activated tissue) the strongly activated area was used to
confirm that the metabolite concentration changes were
related to the visual stimulation.
Finally, a difference spectrum was calculated by subtract-
ing the mean activated spectrum (80 scans/subject, n 5 6,
NT 5 480 scans) from the mean rest spectrum (NT 5 480
scans) following the same procedure as for the individual dif-
ference spectra. To remove the BOLD effect from the spectra
during activation and compensate for the longer T2 (Zhu and
Chen, 2001), an additional line broadening (0.45 Hz) was
applied to the mean activated spectrum prior to Fourier trans-
formation. The resulting BOLD-free difference spectrum was
then quantified with LCModel (Provencher, 1993).
All spectra were fitted and quantified with LCModel using
a basis set including simulated spectra of 20 metabolites with pub-
lished values for chemical shift and J-coupling and an experimen-
tally measured macromolecule baseline, as described by Mekle
et al. (2009). The LCModel analyses were carried out from 0.2
ppm to 4.2 ppm. The Crame´r-Rao lower bound (CRLB), which
gives a measure for the precision of metabolite quantification
assuming that the model function is correct, was used as a marker
of quantification reliability (Provencher, 1993; Cavassila et al.,
2001; Mlynarik et al., 2007). Only metabolites with CRLBs
below 30% were reported, following Mangia et al. (2007).
RESULTS
After adjustment of first- and second-order shim
terms using FAST(EST)MAP, the average water linewidths
in the VOI was 12.9 6 0.7 Hz (mean 6 SD, n 5 6). In
vivo 1H-MR spectra were continuously acquired during
the functional paradigm (Fig. 1A). Physiological motion
such as subject motion or small breathing resulted in a
mean frequency drift of B0 5 2 6 1 Hz (mean 6 SD,
n 5 6) during the fMRS experiment (25 min). The high
stability of the scanner yielded highly reproducible spectra,
and no phase correction was required. A B0 correction was
applied for all 1H spectra before summation and prior to
metabolite quantification. The water residual was generally
minimized to below the height of the NAA peak. Thus,
lipid contamination can be considered to be negligible in
these spectra. Less than 6% of the spectra acquired with
two averages were discarded (criterion is described in
Materials and Methods). The ratio of the height of the
NAA peak (2.01 ppm) to the standard deviation of
the noise in a metabolite-free region of the spectrum
Fig. 1. A: The complete acquisition protocol used in this study lasted
for about 55 min for each subject. An initial gradient echo sequence
and a brief ‘‘localizer’’ fMRI experiment were followed by a shim-
ming procedure using FAST(EST)MAP. The fMRS experiment
lasted for 25 min and consisted of rest periods (black screen) alternat-
ing with activation periods (reversed black–grey checkerboard). Time
courses of glutamate during the functional paradigm (B) in the acti-
vated tissue for six individual subjects and for the summed subjects
and their difference spectra (C). Moving average with a kernel of
4 scans (24 data points) was applied after quantification. Data are
reported as mean values lmol/g. Error bars correspond to the mean
of CRLB divided by the square root of the number of points. Differ-
ence spectra were obtained by subtracting the summed 1H spectra
acquired during stimulation (black blocks) and rest (white blocks)
periods. Metabolite peaks were observed above the noise level of
the difference spectrum (line broadening of 1 Hz was applied to all
spectra).
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(9–10 ppm), for a pair of scans, gave a signal-to-noise ratio
(SNR) of 55 6 4 (mean 6 SD, n 5 6).
To study the metabolite changes of a given indi-
vidual subject within activated tissue, time points were
averaged at a temporal resolution of 30 sec (NT 5 6),
allowing quantification of lactate and glutamate with
CRLB lower than 30% and 4%, respectively. The appli-
cation of a moving average reduced the time resolution
to 60 sec, rendering the changes of glutamate concentra-
tion in the visual cortex visually apparent for each sub-
ject (Fig. 1B). The changes were more apparent when
averaging the time courses over subjects (Fig. 1B, bot-
tom). The increase in glutamate concentration was
observed within the first few minutes of activation.
When comparing activation with rest for each sub-
ject, relative increases of the lactate concentration by 19%
6 4% (P < 0.05, n 5 6) and of the glutamate concentra-
tion by 4% 6 1% (P < 0.001, n 5 6) were found. In
absolute concentration, the lactate increased by 0.12 6
0.03 lmol/g, with a mean control concentration of 0.61
6 0.04 lmol/g, and glutamate increased by 0.33 6 0.05
lmol/g, with a mean control concentration of 9.6 6 0.2
lmol/g. In addition, glucose decreased significantly by
11% 6 3% (P < 0.001, n 5 6), and aspartate had a tend-
ency to decrease by 7% 6 3% (P > 0.05, n 5 6). To
verify the overall spectral stability and reproducibility of
the experiment, difference spectra between the activation
and the rest periods were generated for individual subjects
(Fig. 1C). A BOLD effect on metabolite resonances was
observed in the difference spectra by the presence of a
residual Cr and NAA signal above the noise level induced
by a linewidth narrowing during activation. The line-
width-narrowing effect resulted in an average increase of
the Cr peak height of about 3% between the activation
periods and the following rest periods (data not shown).
Note that increased glutamate was evident in all difference
spectra in Figure 1C.
To investigate further the aforementioned metabo-
lite changes, time points were averaged over the acti-
vated tissue, giving a native time resolution of 20 sec
(Fig. 2A). This allowed quantification of 16 metabolites
with CRLB below 30% (Asp, Cr, PCr, GABA, Glc,
Gln, Glu, GSH, GPC, Ins, Lac, NAA, NAAG, PE,
Scyllo, Tau, GPC 1 PCho; Table I). In particular,
CRLB was below 18% for lactate and below 3% for
glutamate. These CRLBs translated into an average
Fig. 2. A: Group analysis with time courses of metabolite concentra-
tions (24 scans/data point, 75 data points) during the functional para-
digm. Error bars correspond to CRLB (lmol/g). B: Overlap of the
time courses of lactate and glutamate concentration when the voxel
was placed inside (activated tissue, 24 scans/data point, n 5 6; loz-
enges) or outside (nonactivated tissue, 16 scans/data point, n 5 4;
squares) the BOLD activated volume. Moving average with a kernel
of 4 scans (36 data points) was applied after quantification. Data are
reported as the mean metabolite concentration in lmol/g. Error bars
correspond to the mean of CRLB divided by the square root of the
number of points. Relative increases of lactate (19% 6 4%, P <
0.001) and glutamate (4% 6 1%, P < 0.05) were found (n 5 6,
mean 6 SEM).
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precision on the order of 0.2 lmol/g for an average of
24 scans. The application of a moving average shift of
2 scans reduced the time resolution to 40 sec, and the
ensuing time courses depicted an increase of lactate (20%
6 2%) and glutamate (3.4% 6 0.1%) within approxi-
mately the first 2 min of the activation periods (lozenges
in Fig. 2B). An apparent steady-state was reached, which
was maintained until the end of the activation period.
Typically, a return to baseline during the rest period was
observed. Unlike the time courses of the activated tissue,
the nonactivated tissue presented a relatively stable lac-
tate and glutamate concentration (squares in Fig. 2B).
Difference spectra for the nonactivated tissue were also
obtained (not shown) and exhibited noisy flat residuals.
Neither line broadening from a BOLD effect nor metab-
olite signal changes were detected.
To demonstrate further the presence of small metab-
olite changes ascertained by LCModel as described above,
a difference spectrum was obtained from the average of
the six activated tissue (Fig. 3). After correction for the
BOLD effect, lactate and glutamate signal changes were
above the noise level and were quantified with CRLBs
below 25%.The quantification of the difference spectrum
(Fig. 3E) yielded a relative increase of glutamate and lac-
tate of 0.28 6 0.01 lmol/g and 0.18 6 0.01 lmol/g,
respectively. The CRLBs obtained from the quantifica-
tion imply an unequivocal detection of metabolite
changes in the difference spectrum.
DISCUSSION
This study reports metabolite concentration
changes of lactate and glutamate for a small number of
subjects (n 5 6) during physiological stimulation of the
visual cortex. 1H-MR spectra were acquired with high
sensitivity (SNR 5 55 6 4, relative to the height of the
Fig. 3. Summed 1H spectra acquired during activation (A) and rest
(B) periods (n 5 6, 480 scans) were subtracted to yield the difference
spectrum (C). An additional line broadening (asterisk) of 0.45 Hz was
applied to the summed activated spectrum to correct for the BOLD
effect on metabolite linewidth (D). LCModel analysis of the corrected
difference spectrum and the corresponding fits of Glu, Lac, Glc, and
Asp. (E) LCModel metabolite quantification for Glu and Lac was 0.28
6 0.01 lmol/g and 0.18 6 0.01 lmol/g (concentration 6 CRLB),
respectively. Inset: Overlap of the functional map and the anatomical
image was used to place the voxel of interest (VOI 5 20 3 22 3 20
mm3) inside (bottom voxel, activated tissue) or outside (top voxel,
nonactivated tissue) the BOLD activated volume.
TABLE I. Mean Metabolite Concentrations During the Rest
Periods (lmol/g) and the mean Concentration Changes (lmol/g
and Percentage) During the Activation Periods (n 5 6)y
Concentration change
Metabolite
concentration
at rest (lmol/g)
Absolute
(lmol/g) Percentage (%)
Lac 0.61 6 0.04* 0.12 6 0.03* 19 6 4*
Glu 9.6 6 0.2* 0.33 6 0.05* 4 6 1*
Glc 2.0 6 0.2* 20.23 6 0.04* 211 6 3*
Asp 1.6 6 0.2 20.10 6 0.04 27 6 3
Cr 3.9 6 0.1 0.04 6 0.04 1 6 1
PCr 4.1 6 0.1 0.07 6 0.03 2 6 1
GABA 1.2 6 0.1 0.00 6 0.01 0 6 1
Gln 2.3 6 0.1 0.04 6 0.01 2 6 1
GSH 0.7 6 0.1 20.01 6 0.02 22 6 3
GPC 0.6 6 0.1 0.05 6 0.01 4 6 1
Ins 6.0 6 0.2 20.01 6 0.05 0 6 1
NAA 12.0 6 0.2 0.08 6 0.04 1 6 0
NAAG 1.5 6 0.1 0.01 6 0.04 0 6 3
PE 2.6 6 0.1 0.00 6 0.03 0 6 1
Scyllo 0.2 6 0.0 0.02 6 0.01 13 6 4
Tau 0.9 6 0.1 0.07 6 0.03 7 6 3
GPC 1 PCho 0.8 6 0.0 0.02 6 0.01 2 6 1
Tot Cr 8.0 6 0.0 0.10 6 0.04 1 61
Tot NAA 10.7 6 0.8 0.07 6 0.04 1 6 0
ySixteen metabolites were quantified with LCModel with CRLB below
30% (NT 5 24): lactate (Lac), glutamate (Glu), glucose (Glc), aspartate
(Asp), creatine (Cr), phosphocreatine (PCr), g-aminobutyrate (GABA),
glutamine (Gln), glutathione (GSH), glycerophosphocholine (GPC), myoi-
nositol (Ins), N-acetylaspartate (NAA), N-acetylaspartylglutamate
(NAAG), phosphoethanolamine (PE), scylloinositol (Scyllo), taurine (Tau),
glycerophosphocholine 1 phosphocholine (GPC 1 PCho), total creatine
(tot Cr), and total N-acetylaspartate (tot NAA). The concentrations
changes were obtained from the time group analysis (NT 5 80 scans for
rest and for activation periods, n 5 6). Data are expressed as mean 6 SEM.
*Metabolites with significant changes (P < 0.05, two-way ANOVA with
Bonferroni posttest correction).
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NAA peak, NT 5 2), which allowed quantification of
metabolite of interests with CRLB below 18% (NT 5
24). The analyses were based on individual time courses
using a moving average (Fig. 1) or were based on group
analysis by averaging spectra across subjects (Fig. 2) or
were performed by analyzing the difference spectra
between activation and rest (Fig. 3). Results consistently
showed an increase of lactate by 19% 6 3% (P < 0.05)
and of glutamate by 4% 6 1% (P < 0.001), in
agreement with recent studies (Mangia et al., 2007; Lin
et al., 2012).
Based on the fMRI ‘‘localizer’’ scan, the voxel was
placed in a highly activated area of the activated tissue.
Linewidth changes, induced by the BOLD effect (Zhu
and Chen, 2001), were consistently observed for each
subject in the difference spectrum (Fig. 1C). The flat re-
sidual of each difference spectrum illustrated the overall
stability and reproducibility of the experiment. In our
study, the region of 1.3–1.5 ppm was devoid of any
observable variation (except for potential metabolite
changes), and lipid resonances were suppressed to a level
that is unlikely to affect the observed changes in lactate
or other metabolites. In contrast, when the voxel was
placed above the primary visual cortex for the nonacti-
vated tissue, the difference spectrum yielded a flat base-
line, and no BOLD effect was present (data not shown).
The comparison between the metabolite time courses of
the activated tissue and the nonactivated tissue confirmed
that these metabolite changes occurred only where neu-
ronal activation took place (Fig. 2B). However, minor
but statistically nonsignificant metabolite changes were
observed in the time courses of the nonactivated tissue,
which might be induced by some unwanted signal
change resulting from the proximity of the VOI with
respect to the activated area. Therefore, it can be
inferred that substantial metabolite signal changes
occurred only in the inferior voxel (Fig. 3, inset) and
were directly related to the activation of the primary
visual cortex.
The present study differs in that respect from all pre-
vious reports by not focusing primarily on lactate changes
or larger subject groups (Prichard et al., 1991; Merboldt
et al., 1992; Sappey-Marinier et al., 1992; Frahm et al.,
1996; Sandor et al., 2005; Mangia et al., 2007; A.L. Lin
et al., 2010; Y. Lin et al., 2012). The high sensitivity of
the measurements allowed the study of metabolite changes
during functional activity with relatively few subjects (n
5 6) and a small number of averages (NT 5 24), a sub-
stantial improvement compared with a previous study (n
5 12, NT 5 48; Mangia et al., 2007) and consistent
with the nearly twofold increase in sensitivity provided by
SPECIAL over STEAM (Mlynarik et al., 2006; Mekle
et al., 2009). Sixteen metabolites were reliably quantified
with CRLB below 30% (Table I), and their absolute con-
centrations were in agreement with published metabolite
concentrations at 7 T (Mangia et al., 2006; Mekle et al.,
2009; Emir et al., 2012). Although the two are qualita-
tively similar, our study is closer to the study by Mangia
et al. (2007) than that by Lin et al. (2012), who reported
a transient and twofold smaller relative increase of lactate
during stimulation. In addition, Lin et al. (2012) reported
concentration changes for glutathione, aspartate, gluta-
mine, and glycine (2–11%). With the exception of aspar-
tate, whose change was near significance in our study,
and glucose, the other metabolites did not reach signifi-
cance (Table I).
Several experimental reasons may underlie differen-
ces in the reported changes of lactate following visual
stimulation (Prichard et al., 1991; Merboldt et al., 1992;
Sappey-Marinier et al., 1992; Frahm et al., 1996; Sandor
et al., 2005; Mangia et al., 2007; A.L. Lin et al., 2010; Y.
Lin et al., 2012). First, different acquisition sequences
were employed (ISIS, PRESS, STEAM, SPECIAL). Sec-
ond, different stimulation paradigms were used, which
directly affect processing of light stimuli by the retina.
Consequently, the visual cortex might have been differen-
tially stimulated, exciting different neuronal populations,
which would lead to different stimulus response properties
(Zeki, 1990, 2003; Olavarria et al., 1992; Grill-Spector
et al., 1999; Gazzaniga, 2004; Grill-Spector and Malach,
2004; Wandell et al., 2009). Third, we cannot exclude
the possibility that the smaller voxel used here or higher
sensitivity contributes to differences in the metabolite
changes compared with studies at lower field. To take
these issues into account, the use of a short TE combined
with high magnetic field strength (7 T) and the full mag-
netization available from the small VOI (20 3 22 3 20
mm3), by using the spin echo-based SPECIAL sequence,
allowed a substantial gain in sensitivity compared with
previous studies. Note that differences in relative lactate
changes between studies may be due to different baseline
concentrations. Therefore, we provided quantification of
metabolite changes in absolute concentration and percent-
age changes (Table I), which are consistent with recent
studies at 7 T (Mangia et al., 2007; Lin et al., 2012).
It is of interest to note that the physiological stimu-
lation led to a new steady state for lactate and glutamate
after the first minutes of activation (Fig. 2). The plots of
glutamate and lactate time courses during the stimulation
period clearly illustrate a new steady-state level reached by
the metabolites and do not suggest a continuous increase
of glutamate and lactate during physiological stimulation.
After stimulation, the fall of glutamate below the initial
baseline level might be caused by a slower return of
CMRO2 to the baseline compared with CBF, which is
believed to be responsible of the poststimulus BOLD
undershoot (Frahm et al., 1996; Kruger et al., 1996; Lu
et al., 2004; Yacoub et al., 2006).
The initial rise of lactate and glutamate after stimulus
onset results in a net increase of carbon in tissue that
would otherwise be metabolized to CO2 and, therefore,
implies a transient uncoupling of CMRGlc from CMRO2.
The uncoupling of the changes of CMRO2 and CMRGlc
has already been demonstrated in positron emission studies
(PET) studies (Fox and Raichle, 1986; Fox et al., 1988;
Madsen et al., 1995). In contrast, MR studies using a
BOLD effect have reported both linear and nonlinear
coupling for human and animal studies (Hyder et al.,
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2001; Rothman et al., 2003; Dienel and Cruz, 2004; Liu
et al., 2004; Leithner et al., 2010; Lin et al., 2010; Wey
et al., 2011), which has been attributed to different experi-
mental conditions, stimuli, paradigms, frequencies, and
brain regions (Vafaee and Gjedde, 2000, 2004; Rothman
et al., 2003; Zhu et al., 2009). Note, however, that, de-
spite the uncoupling that undoubtedly must have
occurred, an energy balance calculation (not shown) indi-
cates that the energy demands during neuronal activation
are largely met through oxidative metabolism at all times.
In addition to PET and MR studies, flavoprotein
fluorescence imaging has gained interest recently as a
powerful imaging tool for visualizing cortical activity and
investigating neuronal activity (Reinert et al., 2007). The
early and rapid increase of oxidative metabolism observed
with flavoprotein imaging within the first minute of
stimulation (Reinert et al., 2007; Sirotin and Das, 2010)
may indicate that CMRO2 increases substantially, but this
does not affect the conclusion from the study, which is
that an uncoupling must occur transiently.
We conclude that metabolite concentration
changes in the visual cortex during visual activation are
very small (0.1–0.3 lmol/g), yet can be detected at 7 T
with a small number of subjects (n 5 6), which opens
the possibility of assessing smaller activated VOI. We
further conclude that the early transient changes of the
metabolite concentrations likely imply a transient mis-
match between CMRO2 and CMRGlc, the magnitude of
which remains to be determined.
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